Rallybio logo

Rallybio

RLYB | NASDAQ
Chart Builder DCF Calculator
$15.43
-$0.29 (-1.84%)
At close: Nov 16, 2026, 4:00 PM ET
$15.38
-$0.05 (-0.33%)
After-hours: Nov 16, 2026, 7:33 PM ET
-1.84%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
45.8
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #374/1021 (Top 37%)

Key Statistics

Market Data

Market Cap $88.18M
1D Range
15.09 15.98
52W Range
4.33 17.22

Valuation (TTM)

PE 3.44
PB 0.96
EV/EBITDA -0.08

Valuation (NTM)

Forward PE N/A
Forward PEG 0.02
Price Target $0.00
Loading financial charts...

Profile

Rallybio Corporation is a clinical-stage biotechnology firm dedicated to discovering and bringing to market transformative therapies for individuals facing severe and uncommon illnesses. Its most adva...

Sector Healthcare
Industry Biotechnology
Employees 14
IPO Date Jul 29, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.